EE112 Budget Impact Analysis of Bimekizumab for the Treatment of Active Psoriatic Arthritis (PsA) in Greece.
Autor: | Koulentaki, M1 (AUTHOR), Ravanidis, S2 (AUTHOR), Daoussis, D3 (AUTHOR), Dimitroulas, T4 (AUTHOR), Papagoras, C5 (AUTHOR), Sfikakis, P6 (AUTHOR), Kountouris, V7 (AUTHOR), Feretos, M7 (AUTHOR), Kourlaba, G8 (AUTHOR), Lyris, N9 (AUTHOR), Willems, D10 (AUTHOR) |
---|---|
Zdroj: | Value in Health. 2024 Supplement, Vol. 27 Issue 12, pS76-S76. 1p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |